Hints and tips:
Related Special Reports
...Merck’s Covid-19 antiviral pill failed to show it can lower the risks of hospitalisation and death among adults at higher risk from the disease, according to the results of a pivotal clinical trial in the...
Case studies in best practice among general counsel and company legal teams in North America
...Dean Li, president of Merck’s research laboratories, praised the UK’s scientific talent and expertise, hoping that the investment in King’s Cross will help researchers at MSD, known as Merck in the US, work...
...It has brought in a retired Navy admiral, Kirkland H Donald, to review its quality management systems....
...A person familiar with the process said Merck “understood there was no hope . . . [Lagevrio] is a bit burnt”....
...Fogelberg joins from Kirkland & Ellis, where she was a partner and worked with C Street founder Jon Henes, a former Kirkland & Ellis partner....
...Boeing on Tuesday named Kirkland H Donald, a retired Navy admiral, as the independent adviser to lead the assessment....
...The new rules give the federal government the power to negotiate lower prices for some of the most expensive prescription drugs produced by Pfizer, Merck and other pharma companies purchased by Medicare,...
...Molnupiravir, marketed by Merck and co-developed with US biotech group Ridgeback Biotherapeutics, works by inducing small mutations in the virus itself....
...He said Merck’s claim that the reforms were an “extortion” was accurate....
...When Ken Frazier, another law school friend, was CEO of Merck and facing criticism for refusing to cut research budgets, Ogunlesi reassured him he was doing the right thing....
...But the FT reported that months earlier, Merck, a German healthcare and life sciences group, had proposed buying a majority stake in the Japanese company....
...Merck is either optimistic or desperate if it is willing to pay $5bn more than Prometheus’ valuation three days ago. But it has the funds....
...The team has helped Citi win access to partners at law firms including Kirkland & Ellis, Skadden Arps and Sullivan & Cromwell, who have cashed in on a boom in dealmaking in recent years to take home blockbuster...
...Under the terms of the transaction Merck is acquiring Prometheus through a subsidiary....
...“We are encouraged by these findings from Panoramic,” said Merck, which is known as MSD outside North America....
...“When appropriate, Merck seek to protect its additional innovation,” he added. Merck said it continued to point to late 2028 as the most likely timeframe for biosimilar entry into the market....
...Weber is a paid consultant for Merck and Moderna....
...Merck’s Keytruda now tackles 18 tumour types and is set to be the world’s top-selling medicine next year, according to Evaluate Vantage....
...GTCR’s headquarters are steps away from its longtime legal adviser Kirkland & Ellis, which has ridden the private equity wave to become the world’s largest law firm....
...Chief financial officer Caroline Litchfield said the company operates with the highest “ethics and integrity in absolutely everything we do” and is continuing to co-operate with the Senate finance committee...
...SeaGen lacks a permanent chief executive after co-founder Clay Siegall stepped down in May, so Merck may be tempted to push ahead....
...Merck & Co is in talks to buy the cancer biotechnology company SeaGen for about $40bn, according to two people familiar with the matter....
...“Pfizer is very good at selling but historically not renowned as having the R&D engine of a Merck or Lilly....
...Bonuses hit a peak during 2021, when Kirkland & Ellis was handing out so-called “golden handcuff” deals worth up to $250,000 to some mid-level lawyers with job offers elsewhere....
International Edition